BRISTOL-MYERS SQUIBB COMPANY

Official Publications Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Market Closed - Nyse Other stock markets 04:00:01 2024-05-03 pm EDT			5-day change	1st Jan Change
43.99 ^USD	+0.66%		-1.92%	-14.27%

May. 01	HSBC Adjusts Price Target on Bristol-Myers Squibb to $45 From $50	MT
May. 01	Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration	MT

Official Publications

SEC Filing 10Q-1	Apr. 24	CO
Slide show Q1	Apr. 24	CO
1st quarter results	Apr. 24	CO
SEC Filing 8K	Apr. 24	CO
Proxy Statments	Mar. 17	CO
SEC Filing 4K	Mar. 03	CO
SEC Filing 8K	Feb. 21	CO
SEC Filing 10K	Feb. 12	CO
Slide show results	Feb. 01	CO
Annual results	Feb. 01	CO
SEC Filing 8K	Feb. 01	CO
Dividends	Dec. 05	CO
SEC Filing 10Q-3	23-10-25	CO
Slide show Q3	23-10-25	CO
3rd quarter results	23-10-25	CO
SEC Filing 8K	23-10-25	CO
SEC Filing 4K	23-08-27	CO
SEC Filing 8K	23-08-09	CO
Slide show half-year results	23-07-26	CO
1st-half-year results	23-07-26	CO
SEC Filing 10Q-2	23-07-26	CO
SEC Filing 8K	23-07-26	CO
SEC Filing 8K	23-05-03	CO
SEC Filing 4K	23-05-03	CO
SEC Filing 10Q-1	23-04-26	CO

1 2 3

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Headlines

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

January 09, 2024 at 01:06 pm EST

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW